\
&
Contact us
Background stories of how others approached and experienced their European Horizon funding trajectory.
Published on | 1 year ago
Programmes HealthThe METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
Read the full article for details
Funded by Horizon Europe, under call topic HORIZON-WIDERA-2021-ERA-01-80, INSPIRE is Europe's Centre of Excellence on inclusive gender equality in research and innovation. It relies on four Knowledge and Support Hubs to create knowledge in the areas of sustaining change, widening participation, intersectionality and innovation. Moreover, it supports stakeholders in their journey to become more inclusive through 12 Communities of Practice. In this way, INSPIRE aims to develop both cutting-edge knowledge and innovative strategies for gender equality in the European Research Area. INSPIRE brings together 14 partners. The Belgian partner in this project is UHasselt.